Pro Share Advisors LLC Adaptimmune Therapeutics PLC Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.73 - $1.04 $9,830 - $14,004	13,466 New	13,466 $10,000
Q1 2023 May 11, 2023	SELL	$1.06 - $2.16 $1,997 - $4,069	-1,884 Reduced 15.75%	10,077 $10,000
Q4 2022 Feb 02, 2023	SELL	$1.05 - $2.53 $130 - $313	-124 Reduced 1.03%	11,961 $17,000
Q3 2022 Nov 04, 2022	BUY	$1.06 - $2.41 $1,442 - $3,280	1,361 Added 12.69%	12,085 $13,000
Q2 2022 Aug 01, 2022	SELL	$1.33 - $2.28 $4,627 - $7,932	-3,479 Reduced 24.49%	10,724 $18,000
Q1 2022 May 10, 2022	SELL	$1.73 - $4.06 $8,843 - $20,754	-5,112 Reduced 26.47%	14,203 $29,000
Q4 2021 Feb 08, 2022	SELL	$3.5 - $5.68 $34,853 - $56,561	-9,958 Reduced 34.02%	19,315 $72,000
Q3 2021 Nov 12, 2021	BUY	$3.44 - $6.37 $16,350 - $30,276	4,753 Added 19.38%	29,273 $151,000
Q2 2021 Aug 13, 2021	BUY	$3.86 - $5.78 $21,924 - $32,830	5,680 Added 30.15%	24,520 $104,000
Q1 2021 May 14, 2021	SELL	$4.9 - $6.83 $10,608 - $14,786	-2,165 Reduced 10.31%	18,840 $100,000
Q4 2020 Feb 09, 2021	BUY	$4.0 - $9.2 $84,020 - $193,245	21,005 New	21,005 $113,000
Q4 2019 Feb 12, 2020	SELL	$0.72 - $1.43 $16,187 - $32,150	-22,483 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$1.43 - $3.81 $1,973 - $5,257	-1,380 Reduced 5.78%	22,483 $34,000
Q2 2019 Aug 13, 2019	SELL	$3.23 - $5.41 $10,998 - $18,421	-3,405 Reduced 12.49%	23,863 $96,000
Q1 2019 May 15, 2019	BUY	$3.63 - $6.06 $4,806 - $8,023	1,324 Added 5.1%	27,268 $117,000
Q4 2018 Feb 14, 2019	SELL	$3.76 - $14.16 $4,308 - $16,227	-1,146 Reduced 4.23%	25,944 $149,000
Q3 2018 Nov 14, 2018	SELL	$8.27 - $13.56 $4,267 - $6,996	-516 Reduced 1.87%	27,090 $367,000
Q2 2018 Aug 13, 2018	SELL	$10.42 - $13.74 $24,997 - $32,962	-2,399 Reduced 8.0%	27,606 $328,000
Q1 2018 May 14, 2018	SELL	$7.1 - $11.56 $10,500 - $17,097	-1,479 Reduced 4.7%	30,005 $337,000
Q4 2017 Feb 14, 2018	BUY	$6.68 - $8.74 $210,313 - $275,170	31,484	31,484 $210,000

Others Institutions Holding ADAP

# of Institutions

Shares Held

150M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$24.9 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$18.1 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$11.3 Million
1.24% of portfolio
Baillie Gifford & CO

16.8M
Shares

$11.1 Million
0.01% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$8.78 Million
0.46% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $108M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account